13F-HR filed by BROADWOOD CAPITAL INC
BROADWOOD CAPITAL INC filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 7 holding rows worth $799,835,000.
- Accession
- 0000919574-19-005105
- Filer
- CIK 1278387
- Filed
- 2019-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2019
A holdings report, 7 entries on the cover page, a total value of $799,835,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $799,836,000 with VALUE read as thousands by filing date, 13F file number 028-13773. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBROADWOOD PARTNERS, L.P.028-13770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 10,840,630 | $318,498,000 | thousands by filing date | |
| MONSTER BEVERAGE CORP NEW COM | 61174X109 | Stock | 4,679,308 | $298,680,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 420,000 | $65,310,000 | thousands by filing date | |
| AXONENTERPRISEINC | 05464C101 | STOK | 760,062 | $48,804,000 | thousands by filing date | |
| Bowater Inc | 09066L105 | COMMON STOCKS | 33,980,826 | $37,379,000 | thousands by filing date | |
| ONCOCYTE CORP | 68235C107 | COM | 8,098,267 | $20,165,000 | thousands by filing date | |
| AGEX THERAPEUTICS INC | 00848H108 | COM | 2,997,156 | $11,000,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-19-005105 | this filing | 2019-08-14 | acceptance time not in the bulk data set |